Abstract
The monoclonal antibody Y13 259 to the ras oncogene protein product p21 was used in an immunohistochemical study of ras expression in human colorectal neoplasms. The ability of the antibody to detect enhanced levels of ras expression was confirmed by its use with an experimental neoplasm known to express ras at high levels. Human colonic adenocarcinomas in general showed a similar staining intensity to that seen in normal mucosa. Adenomas however showed consistently high p21 expression as indicated by staining intensity. This suggests that elevated ras expression may be important in the development of adenomas, but that high levels need not be sustained in the conversion to invasive carcinoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Williams, A., Piris, J., Spandidos, D. et al. Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms. Br J Cancer 52, 687–693 (1985). https://doi.org/10.1038/bjc.1985.244
Issue Date:
DOI: https://doi.org/10.1038/bjc.1985.244
This article is cited by
-
Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study
BMC Neuroscience (2010)
-
Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview
Cancer and Metastasis Review (1992)